Literature DB >> 70210

The Duffy blood group determinants: their role in the susceptibility of human and animal erythrocytes to Plasmodium knowlesi malaria.

S J Mason, L H Miller, T Shiroishi, J A Dvorak, M H McGinniss.   

Abstract

Duffy blood group negative erythrocytes from blacks are refractory to invasion by Plasmodium knowlesi merozoites in vitro, and blacks with this genotype are resistant to infection by P. vivax in vivo. In order to evaluate in a direct manner the role of Duffy blood group determinants in invasion by P. knowlesi merozoites, we studied erythrocytes from three rare non-black Duffy negative individuals, Fy(a-b-), in whom the Duffy negative phenotype probably represents a mutation and not the introduction of the black Fy gene. These cells were resistant to invasion by P. knowlesi in vitro indicating that resistance to invasion is mediated by the FyFy genotype and not another closely linked factor. The erythrocyte receptors for invasion, however, may not be the Fya or Fyb Duffy antigens themselves, or at least not restricted to these determinants, since refractory Duffy negative human erythrocytes were invaded after treatment with trypsin or neuraminidase although these enzyme-treated cells still lacked Fy a and Fy b determinants. Furthermore, new world monkey erythrocytes and chymotrypsinized chimpanzee and kra monkey erythrocytes were invaded, although there was no serologic evidence of Fya or Fyb determinants on these cells.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 70210     DOI: 10.1111/j.1365-2141.1977.tb00656.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  30 in total

Review 1.  Biochemistry of Plasmodium (malarial parasites).

Authors:  I W Sherman
Journal:  Microbiol Rev       Date:  1979-12

Review 2.  Relationship between infectious diseases and human blood type.

Authors:  S A Berger; N A Young; S C Edberg
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-08       Impact factor: 3.267

3.  Emergence of FY*A(null) in a Plasmodium vivax-endemic region of Papua New Guinea.

Authors:  P A Zimmerman; I Woolley; G L Masinde; S M Miller; D T McNamara; F Hazlett; C S Mgone; M P Alpers; B Genton; B A Boatin; J W Kazura
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-23       Impact factor: 11.205

4.  Plasmodium vivax pre-erythrocytic-stage antigen discovery: exploiting naturally acquired humoral responses.

Authors:  Douglas M Molina; Olivia C Finney; Myriam Arevalo-Herrera; Socrates Herrera; Philip L Felgner; Malcolm J Gardner; Xiaowu Liang; Ruobing Wang
Journal:  Am J Trop Med Hyg       Date:  2012-07-23       Impact factor: 2.345

5.  Domain III of Plasmodium falciparum apical membrane antigen 1 binds to the erythrocyte membrane protein Kx.

Authors:  Kentaro Kato; D C Ghislaine Mayer; Sanjay Singh; Marion Reid; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-01       Impact factor: 11.205

Review 6.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

7.  The interrelationship of tropical disease and mental disorder: conceptual framework and literature review (Part I--Malaria).

Authors:  M G Weiss
Journal:  Cult Med Psychiatry       Date:  1985-06

8.  Recombinant Plasmodium falciparum reticulocyte homology protein 4 binds to erythrocytes and blocks invasion.

Authors:  Deepak Gaur; Sanjay Singh; Subhash Singh; Lubin Jiang; Ababacar Diouf; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2007-10-30       Impact factor: 11.205

Review 9.  Evolutionary and historical aspects of the burden of malaria.

Authors:  Richard Carter; Kamini N Mendis
Journal:  Clin Microbiol Rev       Date:  2002-10       Impact factor: 26.132

10.  Resistance to Plasmodium chabaudi in B10 mice: influence of the H-2 complex and testosterone.

Authors:  F Wunderlich; H Mossmann; M Helwig; G Schillinger
Journal:  Infect Immun       Date:  1988-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.